Nicolas Hubacz: Mesenchymal Stem Cells Are Some of the Most Fascinating Cells in Regenerative Medicine
Nicolas Hubacz, Research and Clinical Products Business Development Manager at Magstim, shared a post on LinkedIn:
“The Body’s Cellular Repair Crew, Mesenchymal stem cells (MSCs) are some of the most fascinating cells in regenerative medicine.
Found in bone marrow, fat tissue, umbilical cord tissue, and other organs, these cells can both transform into specialized cell types and influence healing through powerful signaling mechanisms.
What makes MSCs especially interesting is that their therapeutic potential may come less from ‘becoming new tissue’ and more from how they communicate with the immune system and damaged cells around them.
What MSCs can do:
- Modulate inflammation and immune responses
- Support tissue repair and wound healing
- Differentiate into bone, cartilage, muscle, and fat cells
- Release growth factors and extracellular vesicles that influence surrounding cells
- Serve as a major focus of regenerative medicine and bioengineering research
Researchers are actively studying MSCs in areas ranging from neurodegenerative disease and stroke recovery to orthopedic injury, autoimmune disorders, and cardiovascular disease.
The video of MSCs in motion is a reminder that biology is incredibly dynamic at the microscopic scale. These aren’t static structures — they constantly migrate, interact, signal, and adapt to their environment.
One of the most exciting shifts in recent years has been the growing understanding that stem cell therapies may work through entire cellular ecosystems, not just through cell replacement alone.
Credit to Nanolive SA for the great video!”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026